Media coverage
79
Media coverage
Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet Morningstar.com Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147841388&p=1gw&v=1&x=golWwhqg86ynG-kbP4TPvg Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet Street Insider Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147815202&p=1gw&v=1&x=E0zQWkalW_pi2XzaVYy7tg Persons John Mascarenhas Title CTI BioPharma (CTIC) Granted FDA Accelerated Approval of VONJO Media name/outlet Street Insider Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47153420074&p=1gw&v=1&x=j-mwYQKcSorP2gzknnU5HQ Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet ADVFN UK Country/Territory United Kingdom Date 1/03/22 URL ct.moreover.com/?a=47147833303&p=1gw&v=1&x=idXm6n6DV4ZXo4z3Akp6iw Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet Yahoo! Finance Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147854164&p=1gw&v=1&x=VdVIeqMgTGkPttYT3L7FEw Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet Maryville Daily Times Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147957282&p=1gw&v=1&x=1gTbXUKHMw5xnlys-tXIRg Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet TickerTech.com Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147818606&p=1gw&v=1&x=BTQhLCf1CSuko9ehHw2dcA Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet Market Newsdesk Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147848195&p=1gw&v=1&x=ylPXsmrD92vECWSruXJVNA Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet ProfitQuotes.com Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147822563&p=1gw&v=1&x=rwbgp67R8Ujmn6OFLsGhNQ Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet ADVFN US Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147839791&p=1gw&v=1&x=OdPdKgD8dxVcBAfUsCR_8w Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet Canadian Insider Country/Territory Canada Date 1/03/22 URL ct.moreover.com/?a=47147881358&p=1gw&v=1&x=tRGdPKwCv58BWfV3AW2nxQ Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet Crwe World Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147959591&p=1gw&v=1&x=U_xrklWRnOMBlbxhOO4sQQ Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet Spoke.com Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47148111498&p=1gw&v=1&x=cBFaXsGbkrwHUrEFR5IQlA Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet USA Life Sciences Database Country/Territory Switzerland Date 1/03/22 URL ct.moreover.com/?a=47149634060&p=1gw&v=1&x=qlum4Dsv1C-oMyM2lJoy3A Persons John Mascarenhas Title CTI BioPharma announces FDA Accelerated Approval of VONJO Media name/outlet PharmaTutor Country/Territory India Date 1/03/22 URL ct.moreover.com/?a=47151688528&p=1gw&v=1&x=AD7ujlxNLvu-LUAAGuNf7w Persons John Mascarenhas Title Read more about CTI BioPharma announces FDA Accelerated Approval of VONJO Media name/outlet PharmaTutor Country/Territory India Date 1/03/22 URL ct.moreover.com/?a=47151972559&p=1gw&v=1&x=VBfB7G4ZWt2PWCG49qM6eQ Persons John Mascarenhas Title CTI BioPharma (CTIC) Stock: Why It Surged Today Media name/outlet Pulse 2.0 Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47152183043&p=1gw&v=1&x=GLgzwUB86viR9T5oU1YMGw Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet PipelineReview Country/Territory Spain Date 1/03/22 URL ct.moreover.com/?a=47152455246&p=1gw&v=1&x=t13tv3NZYf6vzTUmH9UlBA Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet WCTV6 Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147822535&p=1gw&v=1&x=LPfQn1unDGv_qf5zI-3aXg Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet KOLD-TV Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147824672&p=1gw&v=1&x=3OJHTzZlhgBWwQjZR0eJ_g Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet WDAM-TV Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147825835&p=1gw&v=1&x=m5tcZ3l8Yk_s7rR4g5qL_Q Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet WDTV Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147827105&p=1gw&v=1&x=03vdgNH8_aAiq_2KpuEvzw Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet KSNB Local4 Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147827785&p=1gw&v=1&x=wfkg0QXNRsXGKe6xMqJVVg Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet NBCNebraskaScottsbluff.com Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147832183&p=1gw&v=1&x=4EW3-1R8MqiMDXFnlS05UA Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet WOWT Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147833874&p=1gw&v=1&x=DspjlzxPY32Jqv3vG1dISA Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet Webcenter 11 Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147832240&p=1gw&v=1&x=xqmh5Imbu0gc5UH_cxyH4A Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet WBTV News Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147831741&p=1gw&v=1&x=Fo-L10E8uPPc6BHrL9rYnA Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet WFLX Fox 29 Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147837510&p=1gw&v=1&x=j9i0TBiPoNXYatXIQ2irig Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet WRDW Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147838321&p=1gw&v=1&x=DcBDUTS0VE946hqmoS6mbg Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet WCJB Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147838889&p=1gw&v=1&x=POodw84RnoA65gHCUaQ4Vw Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet WWNY TV 7 Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147842363&p=1gw&v=1&x=umDzMWxTwxMYqbzDzs3_Vg Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet Fox 8 WVUE New Orleans Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147842355&p=1gw&v=1&x=ClSbO7inxCmQ2tnzTU55TA Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet WIBW Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147842371&p=1gw&v=1&x=Nz4J9sfFa9XYUjsOrUvrBQ Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet WTOK-TV Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147843501&p=1gw&v=1&x=JC49yQurrRlh0dAJ9czwgg Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet Fox 19 Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147843460&p=1gw&v=1&x=cVgc7clsunnn39mOyUfUJA Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet Live 5 WCSC Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147844098&p=1gw&v=1&x=bq_n6zcxgu3n5yhbM6MraA Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet WHSV Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147846656&p=1gw&v=1&x=D8Cq3vXnXE_qbxCsuDFLdA Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet KEYC Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147847965&p=1gw&v=1&x=qojqcsJIwTHTaBocbAZR8g Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet KLTV 7 Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147848371&p=1gw&v=1&x=XvmyIJegRBQ8y3gMQRaY_A Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet My Sun Coast Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147848611&p=1gw&v=1&x=4AzxnRhUwbAt0wKW6sHyzg Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet KPLC TV Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147848740&p=1gw&v=1&x=nxoLKtSBIJJAoa9mT5ny7Q Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet 14 WFIE Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147858304&p=1gw&v=1&x=8AWoQjT7s0s1wdSCnL2ZFw Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet WMBF Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147859842&p=1gw&v=1&x=C1EqeMp9-Lov5Ye01ceapg Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet WBKO Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147860972&p=1gw&v=1&x=OvAfdaoZo6nBOa8GGvejsw Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet WAFB Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147863157&p=1gw&v=1&x=rRXqhART-37tdOkJwcmZUQ Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet WSAW Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147862344&p=1gw&v=1&x=bH8k7LXpAT9W581Rm6aypA Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet KFVS12 Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147863176&p=1gw&v=1&x=QEm0iVugwf7HLmECxuAT6A Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet Kgns.tv Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147863905&p=1gw&v=1&x=i9J74jALNZP1sFK332egOw Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet WTVM Country/Territory Georgia Date 1/03/22 URL ct.moreover.com/?a=47147864754&p=1gw&v=1&x=gt41Xx3WPR1JnRKwAg8bzQ Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet KCBD Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147866416&p=1gw&v=1&x=gkbS14ODVmz4tsUA9bq-OA Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet KOLN/KGIN Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147868001&p=1gw&v=1&x=DZoO4UhClGb0kFxFANoAVg Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet NBC12 Online Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147867929&p=1gw&v=1&x=tYAMnuOQrTGRxrK9Owyi4Q Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet KWQC Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147868437&p=1gw&v=1&x=T5fM4i6bpq2GcbZZngv7yA Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet WCAX TV3 Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147868512&p=1gw&v=1&x=_deL0B6SHRsPhjepIxzeJA Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet Wave 3 Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147869252&p=1gw&v=1&x=tkvnxOqxfSavy35_l5xboA Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet Hawaii News Now Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147870738&p=1gw&v=1&x=NZKQsvLzInO33YGeQ9l8_A Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet KNOE TV8 Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147873455&p=1gw&v=1&x=wBg6XLG7pbtX9A_JTbrnNw Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet KWTX Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147874014&p=1gw&v=1&x=zKhHKKToH0yqcUantUBWSA Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet KOLO TV Reno Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147875000&p=1gw&v=1&x=o4EwKP0_-6cqA9ccw4mXHw Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet KSLA Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147878763&p=1gw&v=1&x=kdGCh8d06w2AGLIksnIGXQ Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet Kait 8 Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147879102&p=1gw&v=1&x=CdkY4xJnjtCPZJLEi8duDw Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet Upper Michigans Source Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147881465&p=1gw&v=1&x=iQfLwaSykXZDJzNttCjZYg Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet WECT TV-6 Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147880952&p=1gw&v=1&x=ifpVRJF-c7BwqBgvP1ugiA Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet WALB 10 Country/Territory Georgia Date 1/03/22 URL ct.moreover.com/?a=47147896684&p=1gw&v=1&x=b4OrT5kVKk0LuZy0l9t31w Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet WLBT Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147896157&p=1gw&v=1&x=o3p-AWS47rdYxHgGeEJghQ Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet Manchester Times Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147944277&p=1gw&v=1&x=YiYdtNf5Xcf2ZQRQ6BpXdw Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet Tullahoma News Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147946411&p=1gw&v=1&x=3QktZLEseEx6AkTEGb5QIA Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet Citizen Tribune Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147960437&p=1gw&v=1&x=_sLeox_huZ3Ywcuo31UL-g Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet WFMZ-TV Online Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147960773&p=1gw&v=1&x=fbon2saNf9oh-kyEwo29Ow Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet Bakersfield.com Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147965928&p=1gw&v=1&x=Hha6IVmcK0Lv7zFs0t31iw Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet Herald Chronicle Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147973280&p=1gw&v=1&x=hNQRCBodM2S3YCXowm6QnA Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet Galveston County Daily News Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147989898&p=1gw&v=1&x=RfsYlzNlkKm8iNQRfNgQCg Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet Elk Valley Times Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47148002856&p=1gw&v=1&x=RtZ1pMW-B0a1cVN9pDzJVQ Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet CTI BioPharma Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47147864872&p=1gw&v=1&x=ayW6WT6XbVaol0I8ecUL0g Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet CW39 NewsFix Country/Territory United States Date 1/03/22 URL ct.moreover.com/?a=47148107083&p=1gw&v=1&x=C1WfXUxcAgi0DIORUZgbZA Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet Central Charts Country/Territory France Date 1/03/22 URL ct.moreover.com/?a=47147826692&p=1gw&v=1&x=QOdTzIA5ymsHIHmmNdUsCQ Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet BioSpace Country/Territory United States Date 28/02/22 URL ct.moreover.com/?a=47148639232&p=1gw&v=1&x=ZhMC4R10M75dl9Ndvo6ulQ Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet India Pharma News Country/Territory India Date 28/02/22 Persons John Mascarenhas Title CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia Media name/outlet Finanzen.net Country/Territory Germany Date 28/02/22 URL ct.moreover.com/?a=47147848070&p=1gw&v=1&x=eh_EbLXn0JQt6QUTtlXeeQ Persons John Mascarenhas